Rhodobacter sphaeroides lipid A (RsDPLA) and SDZ 880.431 (3-aza-lipid X-4-phosphate) are prototypic lipopolysaccharide (LPS) antagonists. Herein, we examined the ability of these structures to regulate murine macrophage tumor necrosis factor (TNF) secretion and LPS-inducible gene expression (tumor necrosis factor alpha [TNF-a] Gram-negative sepsis claims the lives of more than 70,000 people a year in the United States alone (2), and new therapeutic approaches to reduce significantly the mortality associated with sepsis have proven elusive. It is believed that bacterial lipopolysaccharides (LPS) mediate, at least in part, many of the morbid effects of gram-negative infection (18, 32). LPS does not induce these effects directly, but the lipid A portion of the LPS molecule activates leukocytes to secrete inflammatory cytokines and lipids. These mediators, in turn, act on target cells to produce cardiovascular shock, multiorgan failure, and death (18). Thus, intervention in septic shock could theoretically be achieved by blocking the interaction of leukocytes with the lipid A region of LPS.
SDZ 880.431, when present at low concentrations, act in a manner consistent with competitive inhibition of LPS, while at higher concentrations, these structures inhibit certain LPS responses noncompetitively and synergize with LPS for other responses.
Gram-negative sepsis claims the lives of more than 70,000 people a year in the United States alone (2) , and new therapeutic approaches to reduce significantly the mortality associated with sepsis have proven elusive. It is believed that bacterial lipopolysaccharides (LPS) mediate, at least in part, many of the morbid effects of gram-negative infection (18, 32) . LPS does not induce these effects directly, but the lipid A portion of the LPS molecule activates leukocytes to secrete inflammatory cytokines and lipids. These mediators, in turn, act on target cells to produce cardiovascular shock, multiorgan failure, and death (18) . Thus, intervention in septic shock could theoretically be achieved by blocking the interaction of leukocytes with the lipid A region of LPS.
Towards this end, it has been reasoned that nontoxic lipid A precursors or synthetic analogs that could block LPSinduced toxicity might be prepared. Proctor and coworkers (29) , while investigating the biological properties of lipid X, were the first to demonstrate the potential of this approach. In their report, lipid X, a natural monosaccharide precursor of lipid A, was shown to be nontoxic in mice and to reduce markedly the lethality associated with a 100% lethal dose of LPS. Subsequently, several groups have published reports * Corresponding author. on the LPS inhibitory properties of what is now a large number of lipid A and lipid X-like structures (4, 5, 8, 11, 12, 14, 15, 28, 30, 34, 35, 40, 41, 45) . Takayama et al. (35) purified the nontoxic diphosphoryl lipid A of Rhodobacter sphaeroides (RsDPLA) and reported it to inhibit LPS-induced macrophage tumor necrosis factor (TNF) secretion, and Qureshi et al. (30) extended this finding to inhibition of LPS-induced TNF production in vivo. Others have recently reported an inhibitory effect of RsDPLA on LPS-induced lethality in mice (45) , in vitro-acquired LPS tolerance in macrophages (8) , pre-B-cell activation (12) , CD18 surface expression on human neutrophils (15) , and human monocyte TNF secretion (4) . Lipid IVA, a natural precursor of lipid A, similarly blocks the effects of LPS on a variety of human cells (4, 14, 15, 40) , and several synthetic lipid IVA analogs that retain inhibitory activity have been evaluated (40, 41) . Interestingly, treatment of LPS with neutrophil-derived acyloxyacyl-hydrolase removes the 3-acyloxyacyl fatty acids such that the lipid A region of LPS resembles lipid IVA (5) . (Fig. 1) , it is generally believed that they act as competitive receptor antagonists. The specificity of the inhibitors for LPS stimulation and the ability of excess LPS to override inhibition has provided strong, albeit indirect, support for this supposition (4, 8, 12, 14, 15, 30, 34, 35, 40, 41) . Nonetheless, demonstration of competitive binding to the relevant receptor(s) has not been achieved because the identity of the relevant receptor(s) has not been fully delineated. Identifying receptor mechanisms for LPS signaling is currently an active and emerging area of research (reviewed in reference 19) . LPS binds plasma proteins, including a 60-kDa acute-phase LPS-binding protein (33) and septin (42) , and association with one or more of these proteins markedly increases the efficiency of subsequent LPS binding to CD14 on the surface of monocytes (38, 43) . Binding of LPS to CD14 is a key step in LPS signaling because antibodies against CD14 block both binding and stimulation of monocytes by LPS (9, 13, 43) . However, in a recent study, Kitchens et In the present study, we have sought to compare the abilities of the disaccharide inhibitor RsDPLA and the monosaccharide inhibitor SDZ 880.431 to block LPS-induced effects on murine macrophages. We evaluated the expression of a panel of LPS-inducible genes, as readouts of LPS stimulation, which included the tumor necrosis factor alpha (TNF-a), interleukin-l (IL-1p), IP-10, type 2 TNF receptor (TNFR-2), D3, and D8 genes (36) . Our objective was to determine whether the inhibitors uniformly blocked LPS-inducible gene expression or whether they could be used to regulate the expression of this panel of genes differentially and thereby identify potentially divergent effects of the inhibitors on LPS signaling. We report that relatively low concentrations of RsDPLA and SDZ 880.431 suppress induction of all six genes by LPS in an apparently competitive fashion. In contrast, high concentrations of RsDPLA and SDZ 880.431 exhibited a bidirectional effect on macrophage responsiveness to LPS; LPS induction of select genes was noncompetitively blocked, while induction of TNF-a was enhanced about fourfold.
MODULATION OF LPS-INDUCED GENES BY LPS ANTAGONISTS

MATERIALS AND METHODS
Reagents. The water-soluble bis-Tris salt of SDZ 880.431 was synthesized as described previously (34) by Sandoz Research Institute, Vienna, Austria. RsDPLA was prepared by acid hydrolysis of R. sphaeroides LPS and purified by using a DEAE-cellulose acetate column as described previously (31) . Protein-free (<0.008%), phenol-water-extracted Escherichia coli K235 LPS was prepared by the method of McIntire et al. (20) . Heat-killed Staphylococcus aureus (HKSA) was prepared from a log-phase culture by boiling and washing it in H20. The boiled organisms were collected by centrifugation, dried under vacuum, and resuspended (25 mg/ml) in H20 (Limulus amoebocyte lysate activity, <0.3 endotoxin unit per ml).
Macrophage isolation and culture. Female C3H/OuJ mice (6 to 7 weeks old; Jackson Laboratory, Bar Harbor, Maine) were used as the source of macrophages. Mice were housed in a single-vendor, laminar-flow facility under 12-h light-12-h dark cycles and fed standard mouse chow and acidified water ad libitum. Peritoneal exudate macrophages were isolated by peritoneal lavage 4 days after intraperitoneal injection of 2 ml of sterile 3% thioglycolate broth. Cells were washed and resuspended at 2 x 106 cells per ml in RPMI 1640 supplemented with 2 mM glutamine, 100 U of penicillin per ml, 100 ,ug of streptomycin per ml, 10 mM HEPES (N-2-hydroxyethylpiperazine-N'-2-ethanesulfonic acid), 0.3% sodium bicarbonate, and 2% heat-inactivated fetal calf serum. filters and hybridized overnight with random-primed 32P-labeled cDNA probes. Probes included a 1,100-bp cDNA recognizing TNF-a (26) (generously provided by Bruce Beutler, Howard Hughes Medical Institute, Dallas, Tex.), a cDNA probe specific for murine 1-actin (39) (generously provided by Michael Prystowsky, University of Pennsylvania, Philadelphia), and cDNA probes described by Tannenbaum et al. (36) with specificity for five LPS-inducible genes, C7, D3, D5, D7, and D8. C7, D5, and D7 have been identified as encoding IP-10, IL-1,, and TNFR-2, respectively (23, 25, 37) . Hybridized blots were washed three times for 10 min each time at 65°C in 0.1x SSC (lx SSC is 0.15 M NaCl plus 0.015 M sodium citrate) containing 0.1% sodium dodecyl sulfate (SDS). Washed blots were exposed to Kodak XAR-5 film with intensifier screens for 18 to 24 h at -70°C. To quantify relative gene expression, phosphor screens were exposed to hybridized blots for 18 to 24 h at room temperature and analyzed by densitometric analysis with a PhosphorImager and Fast Scan program from Molecular Dynamics (Sunnyvale, Calif.). The ratio of the signal of the probe of interest to that of P-actin was used as a measure of relative induction. Between successive hybridizations, cDNA probes were stripped from the Nytran filters by being boiled in distilled water for 5 min.
RsDPIA and SDZ 880.431 inhibition of LPS-induced TNF secretion. Four-hour culture supernatants (sampled just prior to RNAzol B solubilization of cultures described above) were assayed for TNF-ao bioactivity in a standard cytotoxicity assay using actinomycin D-treated L929 cells as described previously (10) . One unit of TNF-at was defined as the amount of TNF-a required to lyse 50% of the cells. Human recombinant TNF-ot was kindly provided by Cetus Corp. (Emeryville, Calif.), and 1 U of the human recombinant TNF-ot was equivalent to -5 U of activity in our assay system.
Research was conducted according to the principles detailed in Guide for the Care and Use ofLaboratoryAnimals, prepared by the Institute of Laboratory Animal Resources, National Research Council.
RESULTS
Effects of RsDPIA alone on gene induction and TNF secretion. We previously reported that very high concentrations of SDZ 880.431 (50 ,ug/ml) did not induce detectable levels of TNF secretion or macrophage gene expression (27) . Before the inhibitory properties of RsDPLA were examined, the effects of this structure alone on macrophages were evaluated. Peritoneal exudate macrophages were cultured for 4 h in the presence of RsDPLA, SDZ 880.431, or LPS, and RNA was harvested for Northern blot analysis of a panel of genes known to be strongly induced by LPS. The panel included genes encoding TNF-oa, IL-1p, IP-10, TNFR-2, D3, and D8. Supernatants from these same cultures were concurrently tested for TNF activity. When present at high concentrations (21 ,ug/ml), RsDPLA induced low levels of TNF activity and gene expression (Fig. 2) . However, the overall pattern of gene expression stimulated by a high concentration of RsDPLA (20 ,ug/ml) differed qualitatively from the pattern induced by LPS (Table 1) . RsDPLA induced moderate expression of TNFR-2 and TNF-at mRNA but only nominal increases in IL-1p, IP-10, D3, and D8 expression. Consistent with our previous findings, SDZ 880.431 failed to induce TNF-a mRNA and TNF secretion (Fig. 2) (Fig. 3A) . RsDPLA was about 30-fold more potent than SDZ 880.431 as an inhibitor of LPS-induced TNF secretion, and RsDPLA was active as an inhibitor at concentrations lower than those required for its weak agonist activity. In a second series of experiments, the ability of LPS to overcome RsDPLA-and SDZ 880.431-mediated suppression was evaluated (Fig. 3B) . RsDPLA (300 ng/ml) and SDZ 880.431 (5 ,ug/ml) blocked TNF induction by 0.1 and 1 ng of LPS per ml. When LPS was present at .10 ng/ml, TNF secretion was not inhibited. SDZ 880.431 had no effect on TNF secretion induced by genes as a tool to test whether RsDPLA-and SDZ 880.431-mediated blockade of LPS signaling was complete (i.e., all LPS-induced genes were suppressed) or selective (i.e., only a subset of genes was suppressed). Towards this end, RNA harvested from cells treated as described in the legend to Fig. 3A and B was submitted to Northern blot analysis (Fig.  4 and 5) . As little as 10 ng of RsDPLA per ml inhibited by >40% the induction of TNF-a and IL-1,B mRNA by 1 ng of LPS per ml, whereas 300 to 1,000 ng of SDZ 880.431 per ml was required to achieve a similar degree of inhibition. RsDPLA and SDZ 880.431 inhibited the induction of each gene, but the dose dependency for inhibition varied with the gene of interest. For example, it was comparatively more difficult to inhibit, with RsDPLA, induction of TNFR-2, or, with SDZ 880.431, the induction of both TNFR-2 and D3. Figure 5 illustrates that suppression of LPS-induced TNF-a and IP-10 expression (data shown) and IL-1p, TNFR-2, D3, and D8 expression (data not shown) by RsDPLA (300 ng/ml) or SDZ 880.431 (5 ,ug/ml) was overcome when the concentration of LPS was increased to 100 ng/ml. These data are consistent with a proposed mechanism of competitive inhibition.
Gene (Fig. 6 ). Both inhibitors strongly blocked LPS-induced IP-10 and TNF-a gene expression at LPS concentrations of 100 ng/ml. In contrast, at LPS concentrations of 2100 ng/ml, bidirectional effects of SDZ 880.431 and RsDPLA on gene expression could be seen; TNF-a mRNA was superinduced, whereas IP-10 gene expression remained strongly inhibited by both antagonists. Even 50 p,g of LPS per ml could not overcome the inhibitory effects exhibited by 20 ,g ofRsDPLA or SDZ 880.431 per ml on IP-10 expression. Like IP-10 expression, expression of D3 and D8 also remained strongly suppressed, but the expression of IL-1l8 and TNFR-2 was restored (not shown).
To clarify the mechanism for the paradoxical effects observed in the presence of high concentrations of inhibitors, two additional experiments were performed. Relatively high concentrations of LPS can stimulate macrophages in the absence of serum, but LPS-binding proteins present in serum markedly increase macrophage stimulation by low concentrations of LPS (33) . It remains unclear whether signaling elicited by free versus bound LPS is the same or distinct. We postulated that high concentrations of inhibitors may preferentially block serum protein-LPS interactions while allowing stimulation of macrophages by free LPS. If so, gene induction in the absence of serum should resemble gene induction in the presence of serum and excess inhibitors. However, as shown in Table 3 , serum was not required for either the induction of IP-10 or the suppression of IP-10 by SDZ 880.431.
Alternatively, the paradoxical effects of high concentra- ( Fig. 5) . Since strong induction of IP-10 was achieved with the 1:10 dilution (Table 4) , mixed micelle formation is an unlikely explanation for the bidirectional effects of high concentrations of inhibitors.
DISCUSSION
RsDPLA and SDZ 880.431 have been documented to block the stimulatory effects of LPS on a variety of cell types (4, 8, 12, 15, 30, 34, 35) . However, there is a relative lack of information regarding the effects of LPS inhibitors at the level of LPS-inducible gene expression, and herein we have described the comparative inhibition by RsDPLA and SDZ 880.431 of a panel of six genes strongly induced in murine macrophages by LPS. The six genes were chosen, in part, because their collective regulation was known to be divergent and complex. Specifically, it is known that the LPSinduced expression of select genes within this panel are differentially regulated by calcium (24) , gamma interferon (IFN--y) (16a), IL-4 (21), differentiation (22) , and in vitro endotoxin tolerance (7) . Furthermore, alternative stimuli such as IFN-P, IFN--y, IL-2, and HKSA can induce discrete gene subsets within the panel (6, 17, 21) . Thus, it seemed reasonable to speculate that induction of these genes by LPS may involve the activation of diverse signaling pathways, possibly emanating from multiple LPS receptors. In the present study, RsDPLA and SDZ 880.431 inhibited the induction of all six genes when LPS was present at low concentrations. Concentrations of RsDPLA and SDZ 880.431 that inhibited gene expression were consistent with concentrations used by others to inhibit other cellular responses (4, 8, 12, 15, 30, 34, 35 no evidence for LPS-induced cellular responses that are not blocked by lipid A-based inhibitors. Nonetheless, the inhibitor concentrations needed to suppress induction varied with the gene of interest. We cannot currently explain this finding, but the poor suppression of the gene encoding TNFR-2 may relate, in part, to the finding that TNFR-2 is constitutively expressed and induced by 3-to 100-fold-lower concentrations of LPS than those required for the other five genes in the panel (7, 27) . Thus, blockade of minimal receptor occupancy leading to gene induction may be correspondingly more difficult in the case of TNFR-2 expression. Regardless of the mechanism, the results may have important pharmacologic implications. For example, depending on the relative availability of LPS and inhibitor, blockade of LPS-induced functional changes in vivo may, to an extent, be selective. LPS present with lipid A-based (41) , who observed that three of three disaccharide lipid A analogs with inhibitory activity also possessed limited LPS-like activity at high concentrations, while six of seven monosaccharide inhibitors were devoid of stimulatory properties. These data predict that mono-and disaccharide LPS inhibitors may, in general, exhibit distinct biological properties. Disaccharide analogs having pure antagonist properties have, however, been described in vitro (40) , although the concentrations of inhibitors tested in these studies did not exceed 1 p,g/ml.
Other bioactivities of RsDPLA that are distinct from its ability to inhibit LPS have been reported. For example, Baker et al. (1) have shown that RsDPLA partially retains the LPS-like property of reducing suppressor T-cell activity in vivo. Furthermore, Zuckerman and Qureshi (45) have recently reported that RsDPLA protects normal, but not adrenalectomized, mice from LPS-induced serum TNF expression and lethality. High doses of RsDPLA alone induced serum corticosterone in normal mice, and the authors concluded that the protective effects of RsDPLA were a function of its ability to down-regulate LPS responsiveness through the induction and actions of corticosterone, as well as by blocking LPS-macrophage interactions. The mechanism by which RsDPLA induced corticosterone was not delineated but may be related to the stimulatory activity reported herein.
The precise mechanism by which lipid A analogs block LPS effects is unknown, but it is widely assumed that the inhibitors are competitive antagonists of LPS binding to a (as-yet-incompletely-defined) signaling receptor(s). Our data suggest that at low concentrations of inhibitors, competitive inhibition may indeed be a key mechanism, but this model breaks down at high concentrations of inhibitors. Genes induced by high concentrations of LPS are bidirectionally regulated by high concentrations of inhibitors. When RsDPLA or SDZ 880.431 is present at 20 ,ug/ml, induction of several genes (IP-10, D3, and D8) could not be restored by excess LPS, i.e., gene induction was inhibited noncompetitively. Under these same conditions, inhibitors synergized with LPS to induce TNF-a mRNA. Although not shown herein, IL-lp and TNFR-2 gene expression was also induced synergistically with certain combinations of high concentrations of LPS and inhibitors.
We have not been able to dismiss noncompetitive inhibition or synergy by RsDPLA and SDZ 880.431 as artifacts of toxicity or nonspecific cellular effects. In the presence of LPS, 40 ,ug of SDZ 880.431 per ml does not significantly reduce 18-h viability as assessed by trypan blue exclusion (16b). Furthermore, the paradoxical effects of high concentrations of inhibitors are specific for LPS stimulation. SDZ 880.431 (40 p,g/ml) had no effect on gene induction by high or low concentrations of HKSA or on induction of IP-10, D3, D8, or TNF-a by IFN-y (Table 2) (16b). Noncompetitive inhibition or synergy by RsDPLA or SDZ 880.431 occurred independently of serum proteins and could not readily be attributed to formation of mixed micelles. Thus, the bidirectional influence of the inhibitors appeared to involve interactions with macrophages and to effect LPS stimulation selectively.
Although the high concentrations of LPS and inhibitors required to induce bidirectional gene expression are unlikely to occur in vivo, we view the present studies to be useful for the insights they provide into LPS signaling. The results clearly demonstrate a dissociation between LPS signaling leading to IP-10, D3, and D8 and signaling leading to TNF-ot, IL-13, and TNFR-2. Because inhibition was noncompetitive, RsDPLA and SDZ 880.431 appear to induce an uncoupling of the LPS receptor from specific effector pathways required for signaling leading to IP-10, D3, and D8 expression. Under the same conditions, LPS signaling for TNF-a expression was rendered more efficient, possibly by release from a negative influence. We have previously shown that an alternative stimulus, HKSA, strongly induces TNF-a and TNFR-2 expression but only weakly induces IP-10, D3, and D8 expression. Thus, it appears that in the presence of high concentrations of RsDPLA or SDZ 880.431, LPS signaling may resemble the subset of effector pathways activated by HKSA. In a recent publication, inhibition of pertussis-toxinsensitive G proteins blocked LPS-induced nitric oxide production but augmented LPS-induced TNF-a (44). It is tempting to speculate that high concentrations of RsDPLA and SDZ 880.431 may uncouple LPS receptors from specific effector molecules such as G proteins or protein kinases. More work will be required to investigate the influence of RsDPLA and SDZ 880.431 on LPS-induced G-protein activation, protein-tyrosine phosphorylation, and calcium flux. This work will aid in identifying specific signaling pathways leading to gene induction.
